Science and Innovation has decided to focus on several key areas: orthopaedics, oncology and ophthalmology to name a few.
Science and innovation are central to Swiss Medical Network’s activities. Investment in quality research is essential to ensure that diagnostic methods are constantly improved and that the most innovative and safest therapeutic solutions are implemented.
The Genolier Innovation Network offers you and your institution a privileged insight into the research work of the Genolier Innovation Hub in cooperation with the clinics of the Swiss Medical Network. The network also promotes exchange between different players in the healthcare and research sector, links all aspects of the biomedical ecosystem and provides you with resources for innovation.
Genolier Innovation Network is free of charge to any institution or anyone who:
The Genolier Innovation Network is headed by an expert of radio-oncology and nuclear medicine. Dr Jacques Bernier is Chief Science Officer of the Swiss Medical Network. He was a specialist in radio-oncology and nuclear medicine at the University of Liège in Belgium, as well as Head of the Department of Radiation Oncology at the Clinique de Genolier and Medical Director of the Centre d'Oncologie des Eaux-Vives in Geneva from 2006 to 2019.
In 2010, he was honoured with the «Claudius Regaud Medal» by the European Society of Therapeutic Radiology and Oncology (ESTRO). From 2016 to 2019, he was President of the Euro-Asian Association of Mastology - EURAMA, based in Milan. He was also Chairman of the Genolier Cancer Centre until 2019. And since 2023, the Genolier Innovation Network is under his leadership.
Swiss Medical Network has consolidated its research activities by founding «Science and Innovation». The activities of this new science platform are organised into four main areas:
The latest findings are sent quarterly via newsletter. Subscribe to the Science and Innovation Newsletter here.
Science and Innovation has decided to focus on several key areas: orthopaedics, oncology and ophthalmology to name a few.
Professor Guido Garavaglia, Head of Teaching and Research at Clinica Ars Medica, Gravesano, and Professor at the Faculty of Medicine, University of Geneva, developed an IT platform for the implementation of systematic PROM (Patient-Reported Outcome Measures) data collection for all types of clinical activities.
Dr Matti Aapro (Clinique de Genolier) published a large number of peer-reviewed articles in various domains of medical oncology. His numerous research programs in geriatric oncology, breast cancer management and supportive care bear witness to his experience in clinical research protocols and educational activities
“With over 95 scientific publications since 2018, the Swiss Visio Montchoisi Glaucoma Research Centre has quickly become one of the most active centres in Switzerland (and one of the three most active centres in Europe) in this field.” Prof. K. Mansouri
Swiss Medical Network publishes an annual scientific report, presenting the strategies and operational aspects of the research carried out by the Group’s clinics, whether in the context of clinical research developed internally or in the context of programmes carried out in collaboration with external Swiss or international institutions or networks.
Swiss Medical Network’s clinical research programmes are conducted in close collaboration with leading organisations. In Switzerland, these include:
European Institute of Oncology in Milano, Italy
On an international scale, the Group works with the European Organisation for Research and Treatment of Cancer (EORTC) and academic institutions based in New York and Houston.
The Genolier Campus in the Health Valley allows for a new kind of research. The Genolier Campus is a place where research merges with practice and all players in the research and healthcare sector come together. The Clinique de Genolier, the Clinique Nescens and the Genolier Innovation Hub interact with each other here.